 | Up a level |
Journal Article
Corcoran, N. M., Heidenreich, A., Shore, N., Villers, A., Klotz, L., Siemens, D. R., van Os, S., Baron, B., Wang, F. and Chowdhury, S. (2017). Prognostic Factors in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Enzalutamide (ENZA) Or Bicalutamide (BIC) in Terrain. Asia-Pac. J. Clin. Oncol., 13. S. 57 - 58. HOBOKEN: WILEY. ISSN 1743-7563
Heidenreich, A., Shore, N., Villers, A., Klotz, L., Siemens, D. R., van Os, S., Baron, B., Wang, F. and Chowdhury, S. (2016). Prognostic factors in men with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZA) or bicalutamide (BIC) in TERRAIN. Ann. Oncol., 27. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041